Intervention

Atenolol

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 21 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials21
Recruiting1
Common conditions16
Lead sponsors shown15
Advertisement

Clinical trials

21 shown
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early PregnancyNCT04755764 · 2021-03-03
RECRUITING
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.NCT04931108 · 2021-09-27
UNKNOWN
Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular FunctionNCT03082014 · 2018-02-22
TERMINATED
Matão Controlling Hypertension (MatCH Study): Rationale and DesignNCT03147092 · 2018-02-01
UNKNOWN
Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive PatientsNCT01736488 · 2012-10-01
COMPLETED
Hemodynamic Changes of Patients Receiving Atenolol/BisoprololNCT01939509 · 2012-02-01
COMPLETED
A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential HypertensionNCT01251146 · 2010-11-01
COMPLETED
The Confirmatory Olmesartan Plaque Regression StudyNCT01132768 · 2010-05-01
TERMINATED
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 DiabetesNCT00925119 · 2009-12-01
TERMINATED
An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])NCT01079962 · 2009-12-01
COMPLETED
Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood PressureNCT00669279 · 2008-04-01
COMPLETED
The Effect of Nebivolol on Insulin SensitivityNCT00125853 · 2006-07-01
COMPLETED
Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive PatientsNCT00396656 · 2005-12-01
COMPLETED
Pharmacogenomic Evaluation of Antihypertensive ResponsesNCT00246519 · 2005-10-01
COMPLETED
Hypertension in Hemodialysis Patients (Aim 3)NCT00582114 · 2005-08-01
TERMINATED
Black Education and Treatment of Hypertension (BEAT HTN)NCT00661895 · 2005-08-01
COMPLETED
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to InsulinNCT00185094 · 2004-02-01
COMPLETED
A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or PlaceboNCT00158093 · 2003-06-01
COMPLETED
Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With HypertensionNCT00529750 · 2002-07-01
COMPLETED
Olmesartan Medoxomil in AtherosclerosisNCT00185185 · 2001-11-01
COMPLETED
Irbesartan and Atenolol in Hypertensive Heart DiseaseNCT00389168 · 1995-04-01
COMPLETED

Trial status mix

COMPLETED14
TERMINATED4
UNKNOWN2
RECRUITING1

Phase mix

PHASE412
PHASE35
EARLY_PHASE11
NA1
PHASE11
PHASE21
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.